We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 27, 2020

Threshold CEA Change Can Predict Nonprogression in Metastatic Colorectal Cancer With Elevated CEA

Journal of the National Cancer Institute


Additional Info

Journal of the National Cancer Institute
Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA
J. Natl. Cancer Inst 2020 Nov 01;112(11)1127-1136, P Gulhati, J Yin, L Pederson, HJ Schmoll, P Hoff, JY Douillard, JR Hecht, C Tournigand, N Tebbut, B Chibaudel, A Gramont, Q Shi, MJ Overman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading